David Kerr

David Kerr

  • dkerr at bournemouth dot ac dot uk
Back to top

Journal Articles

  • Bowes, A., Hale, A., Haviland, J., Kerr, D., 2013. Obesity trends in people with Type 1 diabetes are the same as for the general UK population. DIABETIC MEDICINE, 30, 105.
  • Little, S., Chadwick, T., Choudhary, P., Brennand, C., Stickland, J., Barendse, S., Olateju, T., Leelarathna, L., Walkinshaw, E., Tan, H.K., Marshall, S.M., Thomas, R.M., Heller, S., Evans, M., Kerr, D., Flanagan, D., Speight, J., Shaw, J.A.M., 2012. Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial). BMC Endocrine Disorders, 12.
  • Boyle, J., Eriksson, M.E.V., Gribble, L., Gouni, R., Johnsen, S., Coppini, D.V., Kerr, D., 2012. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care, 35 (12).
  • Boyle, J., Eriksson, M.E.V., Gribble, L., Gouni, R., Johnsen, S., Coppini, D.V., Kerr, D., 2012. Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain. DIABETES CARE, 35 (12), 2451-2458.
  • Naik, S., Kerr, D., Begley, J., Morton, J., 2012. Influence of local skin temperature and choice of insulin analog on catheter occlusion rates during continuous insulin infusion: an exploratory study. Diabetes Technol Ther, 14 (11), 1018-1022.
  • Marden, S., Thomas, P.W., Sheppard, Z.A., Knott, J., Lueddeke, J., Kerr, D., 2012. Poor numeracy skills are associated with glycaemic control in Type 1 diabetes. Diabet Med, 29 (5), 662-669.
  • Kerr, D., Partridge, H., Knott, J., Thomas, P.W., 2011. HbA1c 3 months after diagnosis predicts premature mortality in patients with new onset type 2 diabetes. Diabet Med, 28 (12), 1520-1524.
  • Kerr, D., Messing, R., Resch, A., 2011. Actionable self-monitoring of blood glucose: redefining the role for patients using multiple daily injection therapy. J Diabetes Sci Technol, 5 (6), 1584-1590.
  • Rana, O., Byrne, C.D., Kerr, D., Coppini, D.V., Zouwail, S., Senior, R., Begley, J., Walker, J.J., Greaves, K., 2011. Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans. Circulation, 124 (14), 1548-1556.
  • Kerr, D., Partridge, H., 2011. Deus ex machina: the use of technology in type 1 diabetes. Prim Care Diabetes, 5 (3), 159-165.
  • Choudhary, P., Shin, J., Wang, Y., Evans, M.L., Hammond, P.J., Kerr, D., Shaw, J.A.M., Pickup, J.C., Amiel, S.A., 2011. Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia Reduction in nocturnal hypoglycemia in those at greatest risk. DIABETES CARE, 34 (9), 2023-2025.
  • Collins, A., Cortes, N., Matthews, B.N., Kerr, D., McCormick, R., 2011. Reversible blindness: severe pneumococcal induced uveitis following septicaemia. BMJ Case Rep, 2011.
  • Rana, O., Kerr, D., Zouwail, S., Coppini, D.V., Begley, J., Byrne, C.D., Senior, R., Greaves, K., 2010. The Effect of Insulin and Insulin-induced Hypoglycemia on Myocardial Blood Flow Reserve in Patients with Complicated Type 1 Diabetes Mellitus. CIRCULATION, 122 (21).
  • Diamant, M., 2010. Sensor-augmented insulin-pump therapy in type 1 diabetes [1]. New England Journal of Medicine, 363 (21), 2070-2071.
  • Kerr, D., Hoogma, R.P.L.M., Buhr, A., Petersen, B., Storms, F.E.M.G., study investigators, 2010. Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion. J Diabetes Sci Technol, 4 (6), 1400-1407.
  • Everett, J., Bowes, A., Kerr, D., 2010. Barriers to improving glycaemic control in CSII. Journal of Diabetes Nursing, 14 (5).
  • Sims, J., Richardson, T., Kerr, D., 2010. Insulin errors in hospital: Time for a radical. Clinical Risk, 16 (3).
  • Rossi, M., Nicolucci, A., Di Bartolo, P., Bruttomesso, D., Girelli, A., Ampudia, F., Kerr, D., Ceriello, A., Mayor, C., Pellegrini, F., Horwitz, D., Vespasiani, G., 2010. Diabetes Interactive Diary: A New Telemedicine System Enabling Flexible Diet and Insulin Therapy While Improving Quality of Life. An open-label, international, multicenter, randomized study. Diabetes Care, 33, 109-115.
  • Marden, S., Thomas, P., Knott, J., Kerr, D.. Numeracy and diabetes: the elephant in the room. Lancet.
  • Kerr, D., Olateju, T., 2010. Pascal’s Wager: Combining continuous glucose monitoring and continuous subcutaneous insulin infusion. Diabetes Technology and Therapeutics.
  • Everett, J., Kerr, D.. Telehealth as adjunctive therapy in insulin pump treated patients: a pilot study. Practical Diabetes International, 27.
  • Hammond, P.J., Amiel, S.A., Dayan, C.M., Kerr, D., Pickup, J., Shaw, J.A.M., Campbell, F.M., Greene, S.A., Hindmarsh, P.C.. ABCD position statement on continuous glucose monitoring: use of glucose sensing in outpatient clinical diabetes care. Practical Diabetes International, 27.
  • Kerr, D.. Googled yourself lately? Your patients probably have. Diabetes Digest, 9.
  • Kerr, D., Olateju, T., 2010. Driving with Diabetes in the Future: In-Vehicle Medical Monitoring. Journal of Diabetes Science and Technology, 4, 464-469.
  • Kerr, D., Partridge, H.. Deus Ex Machina. Use of technologies in diabetes care. Primary Care Diabetes.
  • Kerr, D.. Wrath of Grapes. Diabetes Digest.
  • Kerr, D., Bowes, A.. Alcohol and Calories. Lancet.
  • Everett, J., Bowes, A., Kerr, D.. Barriers to improving control with CSII. Journal of Diabetes Nursing.
  • Sims, J., Richardson, T., Kerr, D.. Insulin errors in hospital: time for a radical re-think on risk? Clinical Risk, 16.
  • Kerr, D., Marden, S., 2010. Numeracy and insulin pump therapy. Diabetic Medicine, 27, 730-731.
  • Todres, L., Keen, S., Kerr, D., 2010. Continuous subcutaneous insulin infusion in type 1 diabetes: patient experiences of 'living with a machine'. Diabetic Medicine, 27, 1-5.
  • Kerr, D.. The Boy Done Good (Editorial). Diabetes Digest.
  • Todres, L., Keen, S., Kerr, D., 2010. Continuous subcutaneous insulin infusion in Type 1 diabetes: patient experiences of ‘living with a machine’. Diabetic Medicine, 27, 1201-1204.
  • Eriksson, M., Coppini, D., Gouni, R., Kerr, D., Knight, R., Boyle, J., 2010. CLINICAL SLEEP VARIABLES IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY. SLEEP, 33, A289.
  • Partridge, H., Kerr, D., 2009. Advantages of insulin pump therapy: Letter: Original Observation. Diabetic Medicine, 26 (12).
  • Vespasiani, G., Rossi, M.C., Di Bartolo, P., Sardu, C., Bruttomesso, D., Dal Pos, M., Girelli, A., Zarra, E., Ampudia, F., Kerr, D., Ceriello, A., De La Cuesta, C., Pellegrini, F., Horwitz, D., Nicolucci, A., 2009. Comparison between the "Diabetes Interactive Diary" telemedicine system and standard carbohydrate counting education: an open label, international, multicentre, randomised study. DIABETOLOGIA, 52, S388.
  • Rana, O.A., Zouwail, S., Begley, J., Kerr, D., Coppini, D.V., Senior, R., Greaves, K., 2009. The effect of hypoglycaemia on myocardial blood flow reserve and endothelin-1 levels in healthy non-diabetic subjects using myocardial contrast echocardiography. EUROPEAN HEART JOURNAL, 30, 457.
  • Hickish, T.F., Astras, G., Thomas, P., Penfold, S., Purandare, L., Kerr, D., 2009. Glucose intolerance during adjuvant chemotherapy for breast cancer. Correspondence. Journal of the National Cancer Institute, 101, 537.
  • Richardson, T., Baker, J., Thomas, P.W., Meckes, C., Rozkovec, A., Kerr, D., 2009. Randomized control trial investigating the influence of coffee on heart rate variability in patients with ST-segment elevation myocardial infarction. Quarterly Journal of Medicine, 102, 555-561.
  • Fayers, K., Kerr, D.. CSII Pumps up the Volume of Approval. Diabetes Research and Clinical Practice.
  • Bolli, G.B., Kerr, D., Thomas, R., Torlone, E., Sola-Gazagnes, A., Vitacolonna, E., Selam, J., Home, P., 2009. Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study. Diabetes Care, 32, 1170-1176.
  • Kerr, D., Penfold, S., Zouwail, S., Thomas, P., Begley, J.P., 2009. The influence of liberal alcohol consumption on glucose metabolism in patients with type 1 diabetes. A pilot study. Quarterly Journal of Medicine, 102, 169-174.
  • Edmonds, M., European, Group, A.A.D.F.U.S., Kerr, D.. Apligraft in the treatment of neuropathic diabetic foot ulcers. International Journal of Lower Extremity Wounds, 8.
  • Richardson, T., Baker, J., Thomas, P., Meakes, C., Rozkovec, R., Kerr, D.. Randomised controlled trial investigating the influence of coffee in patients with ST-segment elevation myocardial infarction. Quarterly Journal of Medicine, 102.
  • Cooke, D., Hurel, S., Casbard, A., Steed, L., Walker, S., Meredith, S., Nunn, A., Manca, A., Sculpher, M., Barnard, M., Kerr, D., Weaver, J., Ahlquist, J., Newman, S., 2009. Randomised controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin treated diabetes (MITRE study). Diabetic Medicine, 26, 540-547.
  • Shaban, C., Fosbury, J., Cavan, D.A., Kerr, D., Skinner, T., 2009. The relationship between generic and diabetes specific psychological factors and glycaemic control in adults with type 1 diabetes. Diabetes Research and Clinical Practice, 85, 26-29.
  • Partridge, H., Kerr, D.. Gastrointestinal upset following improvement of HbA1c on initiation of insulin pump therapy. Practical Diabetes International, 26.
  • Newman, S., Cooke, D., Casbard, A., Walker, S., Meredith, S., Nunn, A., Steed, L., Manca, A., Sculpher, M., Barnard, M., Kerr, D., Weaver, J., Ahlquist, J., Hurel, S., 2009. A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE). Health Technology Assessment., 13.
  • Kerr, D.. Fiscal failures and corporate controversy. Diabetes Digest, 8.
  • Kerr, D.. Addressing the imbalance of international diabetes care. Diabetes Digest, 8.
  • Kerr, D.. Thumbs up for NICE guidelines. Diabetes and Primary Care, 11.
  • Kerr, D.. The rocky, yet unremarkable road of media hype. Diabetes Digest, 8.
  • Kerr, D.. Deus ex Machina. Diabetes Digest, 8.
  • Kerr, D., Partridge, H.. Smart insulin pump therapy: consumable costs and considerations. Infusystems International, 8.
  • Kerr, D., 2009. Individualism and insulin pump therapy. Diabetologia, 52, 362.
  • Partridge, H., Kerr, D., 2009. Letter: Original Observation. Advantages of insulin pump therapy. Diabetic Medicine, 26, 1306.
  • Partridge, H., Kerr, D.. Advantages of insulin pump therapy. Diabetic Medicine, 26.
  • Kerr, D., 2008. Continuous subcutaneos insulin infusion therapy and children with type 1 diabetes mellitus: The 2008 updated NICE guidelines. British Journal of Diabetes and Vascular Disease, 8 (SUPPL. 1).
  • Vespasiani, G., Rossi, M.C., Nicolucci, A., Di Bartolo, P., Sardu, C., Bruttomesso, D., Dal Pos, M., Zarra, F., Girelli, A., Ampudia, F.J., Kerr, D., Ceriello, A., De la Questa, C.M., Pomili, B., Horwitz, D., 2008. Comparison between the "Diabetes Interactive Diary" system and standard carbohydrate counting education: an open label, multicentre, randomised study. DIABETOLOGIA, 51, S101-S102.
  • Kerr, D., Nicholls, H., James, J., 2008. Continuous subcutaneous insulin infusion (CSII insulin pump therapy) for type 1 diabetes: a Bournemouth perspective. Practical Diabetes International, 25.
  • Kerr, D., Bdiri, A., 2008. Quinine-associated hypoglycaemia causing diabetes. Diabetic Medicine, 25 (2).
  • Penfold, S., Gouni, R., Hamilton, P., Richardson, T., Kerr, D., 2008. Immediate in-patient management of hyperglycaemia: confusion rather than consensus? QJM, 101, 87-90.
  • Kerr, D., Fayers, K.. Continuous real-time glucose monitoring systems: time for a closer look. Practical Diabetes International, 25.
  • Kerr, D., 2008. A life in the day of Mrs W. Clinical Medicine: Journal of the Royal College of Physicians of London, 8, 515-516.
  • Kerr, D., Morton, J., Whately-Smith, C., Everett, J., Begley, J.P., 2008. Laboratory-Based Non-Clinical Comparison of Occlusion Rates Using Three Rapid-Acting Insulin Analogs in Continuous Subcutaneous Insulin Infusion Catheters Using Low Flow Rates. Journal of Diabetes Science and Technology, 2, 450-455.
  • Kerr, D., Bdiri, A., 2008. Letters: Quinine-associated hypoglycaemia causing diabetes. Diabetic Medicine, 25, 241-242.
  • Kerr, D.. All change at the top (Editorial). Diabetes Digest, 7.
  • Kerr, D.. The forgotten few. Diabetes Digest, 7.
  • Goeke, B., Hershon, K., Kerr, D., Calle Pascual, A., Schweizer, A., Foley, J., Shao, S., Dejager, S., 2008. Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug- Naïve Patients with Type 2 Diabetes: Comparison with Metformin. Hormone and Metabolic Research, 40, 892-895.
  • Kerr, D., James, J., Nicholls, H.. Technologies as therapeutic devices. What do we expect from users of insulin pump therapy. Infusystems International, 7.
  • Kerr, D.. Review: Continuous Subcutaneous Insulin Infusion Therapy and Children with Type 1 Diabetes Mellitus: The 2008 Updated NICE Guidelines. British Journal of Diabetes and Vascular Disease, 8.
  • Kerr, D.. The Tomato Effect. Diabetes Digest, 7.
  • James, J., Thomas, P., Kerr, D., 2007. Preventing childhood obesity: two year follow-up results from the Christchurch obesity prevention programme in schools (CHOPPS). British Medical Journal, 335, 762-764.
  • Nicholls, H., Marden, S., Kerr, D., Richardson, T., 2007. How should we be assessing glucose tolerance postpartum? DIABETIC MEDICINE, 24, 115.
  • Trowbridge, S., Cavan, D., Kerr, D., Richardson, T., 2007. Is a care pathway for diabetes in the dying well received by the Palliative Care team? DIABETIC MEDICINE, 24, 69.
  • Knott, J., James, J., Richardson, T., Cavan, D.A., Kerr, D., 2007. Premature mortality following the diagnosis of Type 2: is it going in the right direction? DIABETIC MEDICINE, 24, 114.
  • Pandey, K., Sriraman, R., Kerr, D., Richardson, T., 2007. Unprecipitated lactic acidosis in a patient on modified-release metformin. DIABETIC MEDICINE, 24, 108.
  • Nicholls, H., Everett, J., Richardson, T., Kerr, D., 2007. Insulin pumps, patients choose to keep it simple. DIABETIC MEDICINE, 24, 120.
  • Young, J.M., Kerr, D., Gouni, R., Penfold, S., 2007. Response to treatment for painful diabetic neuropathy in a dedicated multidisciplinary clinic. DIABETIC MEDICINE, 24, 85.
  • Trowbridge, S., Knott, J., Cavan, D., Richardson, T., Kerr, D., 2007. Lifestyle improvement for everyone. Re-visiting lifestyle education before insulin initiation. DIABETIC MEDICINE, 24, 94.
  • Kerr, D., Knott, J., Cavan, D.A.. The changing shape of type 2 diabetes. Practical Diabetes International, 24.
  • Kerr, D., 2007. Information in diabetes care: is there a need to dumb down even more? Diabetic Medicine, 24, 561-563.
  • Kerr, D., Cheyne, E.H., Thomas, P., Sherwin, R.S., 2007. Influence of acute alcohol ingestion on the hormonal responses to modest hypoglycaemia in patients with Type 1 diabetes. Diabetic Medicine, 24, 312-316.
  • Rosenthal, M.J., Smith, D., Yaguez, L., Giampietro, V., Kerr, D., Bullmore, E., Brammer, M., Williams, S.C.R., Amiel, S.A., 2007. Caffeine restores regional brain activation in acute hypoglycaemia in healthy volunteers. Diabetic Medicine, 24, 720-727.
  • Heller, S.R., Kerr, D., 2007. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia, 50, 1140-1147.
  • Miles, P., Kerr, D., Richardson, T.. Cutaneous problems in insulin therapy. MIMS Dermatology, 3.
  • Kerr, D.. Who’s taking what and is it the real thing? Diabetes Digest, 6.
  • Kerr, D.. A socialist, capitalist or pipe-and-slippers approach to diabetes research? Diabetes Digest, 6.
  • Kerr, D.. Insulin initation in type 2 diabetes. More science than art. Diabetes Digest, 6.
  • Kerr, D.. Laying the foundations of a QOF for specialist diabetes care. Diabetes Digest, 6.
  • Kerr, D.. The changing face of diabetes specialist services: making it work. Diabetes and Primary Care, 9.
  • Richardson, T., Kerr, D., 2007. Ergotamine use in severe diabetic autonomic neuropathy (Letter). Diabetic Medicine, 24, 103.
  • Kerr, D., 2006. I married a SEN. Nursing Times, Novermber 14.
  • Kar, P.S., Goonawardene, M., Kerr, D., 2006. Emphysematous pyelonephritis: Early diagnosis results in avoidance of surgical intervention. Practical Diabetes International, 23 (4).
  • Edmonds, M., Foster, A., Jemmott, T., Kerr, D., Malik, R., Knowles, A., Jude, E., Chadwick, P., Rahaman, L., Murray, N., 2006. Kerraboot vs Allevyn for treating diabetic foot ulcers. Wounds UK, 2.
  • Riveline, J.P., Tubiana-Ruffi, N., Dardari, D., Delcroix, C., Battelino, T., Bolinder, J., Bosi, E., Deiss, D., Kerr, D., Phillip, M., Charpentier, G., Czernichow, P., 2006. Improvement of the glycemic equilibrium in patients with diabetes type 1 using system of the continued evaluation of the glucose by reading the results in real-time: results of the Guardcontrol study. DIABETES & METABOLISM, 32, S15.
  • Hoogma, R.P.L.M., Hammond, P.J., Gomis, R., Kerr, D., Bruttomesso, D., Bouter, K.P., Wiefels, K.J., de la Calle, H., Schweitzer, D.H., Pfohl, M., Torlone, E., Krinelke, L.G., Bolli, G.B., 2006. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabetic Medicine, 23, 141-147.
  • Shaban, M.C., Fosbury, J., Kerr, D., Cavan, D.A., 2006. The prevalence of depression and anxiety in adults with Type 1 diabetes. Diabetic Medicine, 23, 1381-1384.
  • Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., Phillip, M., 2006. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care, 29, 2730-2732.
  • Kar, P.S., Goonawardene, M., Kerr, D.. Diabetes vignette: emphysematous pyelonephritis: early diagnosis results in avoidance of surgical intervention. Practical Diabetes International, 23.
  • Evans, K.M., Kerr, D., Flanagan, D.E.H.. Diabetes and alcohol: time for realistic advice based on the evidence. Practical Diabetes International, 23.
  • Kerr, D.. Shifting care to the community: the political punch of Richard & Judy. Diabetes Digest, 5.
  • Kerr, D.. Changing diabetes care on a cosmological scale. Diabetes Digest, 5.
  • Kerr, D.. Data equals power. Ensuring medicines do what they say on the tin. Diabetes Digest, 5.
  • Kerr, D.. More emphasis on the first two Rs, less on the third please! Diabetes Digest, 5.
  • Cavan, D.A., Kerr, D., Everett, J.. Warning worries (Letter). Balance.
  • Kerr, D., Richardson, T., 2006. Treating insulin allergy with continuous subcutaneous insulin infusion (CSII)(Letter). Diabetic Medicine, 23, 1159.
  • Kerr, D., 2005. Overweight children and adolescents (Letter). New England Journal of Medicine, 353, 1070-1071.
  • Ludwig, D.S., Ebbeling, C.B., Kerr, D., Dietz, W.H., Robinson, T.N., 2005. Overweight children and adolescents [5] (multiple letters). New England Journal of Medicine, 353 (10).
  • Kerr, D., 2005. As fit as a butcher's dog. Lancet, 365 (9475).
  • Trowbridge, S., Kerr, D., 2005. Opening Pandora's box: Home assessments for people with diabetes are revealing. Practical Diabetes International, 22 (1).
  • Richardson, T., Thomas, P., Ryder, J., Kerr, D., 2005. Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes. Diabetes Care, 28, 1316-1320.
  • Everett, J., Kerr, D.. Measuring the impact of type I diabetes from the patient's perspective. Journal of Diabetes Nursing, 9.
  • Richardson, T., Weiss, M.J., Thomas, P., Kerr, D., 2005. Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care, 28, 1801-1802.
  • Trowbridge, S., Kerr, D.. Diabetes vignette: opening Pandora's box: home assessments for people with diabetes are revealing. Practical Diabetes International, 22.
  • Kerr, D., 2005. Uses of error: as fit as a butcher's dog. The Lancet, 365, 1981.
  • Kerr, D., Everett, J., 2005. Coffee, diabetes and insulin sensitivity. Diabetologia, 48, 1418.
  • Kerr, D.. Diabetes care in 2005: what’s it all about? Diabetes Digest, 4.
  • Kerr, D.. Diabetes and alcohol. Diabetes Digest, 4.
  • Kerr, D.. Inpatient insulin: keeping an eye on intensiveness and intricacy. Diabetes Digest, 4.
  • Kerr, D.. Cancer, diabetes and metformin. Diabetes Digest, 4.
  • Knott, J., Cavan, D.A., Kerr, D.. Transfer of a diabetes education program to primary care. Journal of Diabetes Nursing, 9.
  • Everett, J., Kerr, D.. Attendance failures in diabetes clinic (Letter). Practical Diabetes International, 16.
  • James, J., 2004. Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial (vol 328, pg 1237, 2004). BRITISH MEDICAL JOURNAL, 328 (7450), 1236.
  • Richardson, T., Rozkovec, A., Thomas, P., Ryder, J., Meckes, C., Kerr, D., 2004. Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes. DIABETES CARE, 27 (5), 1127-1131.
  • James, J., Thomas, P., Cavan, D.A., Kerr, D., 2004. Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. British Medical Journal, 328, 1236-1240.
  • Kar, P.S., Meredith, S., Crick, M., Kerr, D., 2004. A case of bilateral retinal vein occlusion. Practical Diabetes International, 21 (5).
  • Cheyne, E.H., Sherwin, R.S., Lunt, M.J., Cavan, D.A., Thomas, P., Kerr, D., 2004. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for Type 1 diabetes. Diabetic Medicine, 21, 230-237.
  • Richardson, T., Rozkovec, A., Thomas, P., Ryder, J., Meckes, C., Kerr, D., 2004. Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes. Diabetes Care, 27, 1127-1131.
  • Kar, P.S., Meredith, S., Crick, M.D., Kerr, D.. Diabetes vignette: a case of bilateral retinal vein occlusion. Practical Diabetes International, 21.
  • Avery, L., Borsey, D.Q., Greene, S.A., Gummerson, I., Hayes, R., Kerr, D., Lean, M.E.J., Marshall, S.M., Mcinnes, A., Pierce, M., Roland, J., Sinclair, A.J., Tadman, J., Walton, A., Wiles, P.. British Diabetic Association guidelines on genetic and immune screening for Type 1 diabetes mellitus. Diabetic Medicine, 15.
  • Owens, D., Barnett, A.H., Pickup, J., Kerr, D., Bushby, P., Hicks, D., Gadsby, R., Frier, B.. Blood glucose self-monitoring in type 1 and type 2 diabetes: reaching a multidisciplinary consensus. Diabetes and Primary Care, 6.
  • Richardson, T., Kerr, D.. Acute hypoglycaemia: diagnostic criteria, investigation and management for the emergency physician. Acute Medicine, 3.
  • James, J., Kerr, D., 2004. Prevention of childhood obesity by reducing soft drinks. International Journal of Obesity, 29, S54-S57.
  • Kerr, D.. Diabetes and old age. Who cares? Diabetes Digest, 3.
  • Kerr, D.. A severe case of doing well. Diabetes Digest, 3.
  • Everett, J., Kerr, D.. Earning insulin pump therapy. Practical Diabetes International, 21.
  • Kerr, D.. Try now and analyse later with home glucose testing. Diabetes Digest, 3.
  • Kerr, D.. If it does what it says on the tin. Diabetes Digest, 3.
  • Sharman, D., Richardson, T., Kerr, D.. Old people, feet and too much sugar - a terrible trio. CME Geriatric Medicine, 6.
  • Richardson, T., Kerr, D.. Modern aspects of diabetes monitoring. Postgraduate Doctor Africa, 26.
  • Kerr, D., Cavan, D.A., Everett, J.. Diabetes - whats in a name? (Letter). Diabetic Medicine, 15.
  • Kerr, D., 2003. Of Struldbruggs, sugar, and gatekeepers: a tale of our times. British Medical Journal, 327, 1451.
  • James, J., Thomas, P., Kerr, D., 2003. Letter: Waist Circumference, A Problem all Round (Rapid Response). British Medical Journal.
  • Kerr, D., 2003. Involving patients can work in home blood glucose testing (Letter). British Medical Journal, 326, 103.
  • Watson, J.M., Sherwin, R.S., Deary, I.A., Scott, L., Kerr, D., 2003. Dissociation of augmented physiological, hormonal and cognitive responses to hypoglycaemia with sustained caffeine use. Clinical Science, 104, 447-454.
  • Everett, J., Jenkins, E.J., Kerr, D., Cavan, D.A.. Implementation of an effective outpatient intensive education programme for patients with type 1 diabetes. Practical Diabetes International, 20.
  • Kerr, D., Everett, J.. Assessment of reduced awareness of hypoglycaemia. Journal of Diabetes Nursing, 7.
  • Plougmann, S., Hejlesen, O.K., Turner, B., Kerr, D., Cavan, D.A., 2003. The effect of alcohol on blood glucose in Type 1 diabetes—metabolic modelling and integration in a decision support system. International Journal of Medical Informatics, 70, 337-344.
  • Trowbridge, S., Cavan, D.A., Kerr, D.. Running a nurse-led hypertension clinic to empower patients and achieve blood pressure targets. Practical Diabetes International, 20.
  • Richardson, T., Kerr, D.. Obesity in type 2 diabetes – local experience in a district general hospital. British Journal of Diabetes and Vascular Disease, 3.
  • Kerr, D., Everett, J.. Modern insulin pump therapy. Modern Diabetes Management, 4.
  • Richardson, T., Kerr, D., 2003. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. American Journal of Clinical Dermatology, 4, 661-667.
  • Kerr, D.. Diabetology is a wonderful job. Diabetes Digest, 2.
  • Kerr, D.. Moving the microscope – preventing heart disease in type 1 diabetes. Diabetes Digest, 2.
  • Kerr, D.. How do we define the expert patient? Diabetes Digest, 3.
  • Kerr, D.. UK diabetes care in 2003: a view from outer space. Diabetes Digest, 2.
  • Kerr, D., Trowbridge, S., Allen, S.C.. Guideline, targets and protocols. Look before you leap! British Medical Journal, 326.
  • Kerr, D., James, J., 2002. Nutrition, physical activity, and obesity (Letter). The Lancet, 360, 1249.
  • Summers, J.B., Kaminski, J.M., Kerr, D., James, J., Das, U.N., Meguid, M.M., Jacobson, M.F., 2002. Nutrition, physical activity, and obesity [1] (multiple letters). Lancet, 360 (9341), 1249-1250.
  • Kerr, D., 2002. Ethics and money are not good bedfellows (Letter). British Medical Journal, 324.
  • Kerr, D., 2002. Fifth revision of Declaration of Helsinki - Ethics and money are not good bedfellows. BMJ-BRITISH MEDICAL JOURNAL, 324 (7343), 975-976.
  • Lunt, M.J., Hanrahan, A., Kerr, D., Jenkinson, D.F., 2002. Measuring caffeine-induced changes in middle cerebral artery blood velocity using transcranial Doppler in patients recovering from ischaemic stroke. Physiological Measurement, 23, 375-383.
  • James, J., Thomas, P., Kerr, D.. Childhood obesity: a big problem for small people. Diabetes and Primary Care, 4.
  • Ward, A., Watson, J.M., Wood, P., Dunne, C., Kerr, D., 2002. Glucocorticoid epidural for sciatica: metabolic and endocrine sequelae. Rheumatology, 41, 68-71.
  • Abi-Saab, W.M., Maggs, D., Jones, T., Jacob, R., Srihari, V., Thompson, J., Kerr, D., Leone, P., Krystal, J.H., Spencer, D.D., During, M.J., Sherwin, R.S.. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. Journal of Cerebral Blood Flow & Metabolism, 22.
  • Flanagan, D.E.H., Pratt, E., Murphy, J., Vaile, J.C., Petley, G.W., Godsland, I.F., Kerr, D., 2002. Alcohol consumption alters insulin secretion and cardiac autonomic activity. European Journal of Clinical Investigation, 32, 187-192.
  • Kerr, D., Gillam, E., Ryder, J., Trowbridge, S., Cavan, D.A., Thomas, P.. An Eastern art form for a Western disease: randomised controlled trial of yoga in patients with poorly controlled insulin-treated diabetes. Practical Diabetes International, 19.
  • Watson, J., Deary, I.A., Kerr, D., 2002. Central and peripheral effects of sustained caffeine use: tolerance is incomplete. British Journal of Clinical Pharmacology, 54, 400-406.
  • Cheyne, E.H., Cavan, D.A., Kerr, D., 2002. Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers. Diabetes Technology & Therapeutics, 4, 607-613.
  • Plougmann, S., Hejlesen, O.K., Turner, B., Kerr, D., Cavan, D.A., 2002. Modelling the effect of alcohol in Type 1 diabetes. Studies in health technology and informatics, 90, 66-71.
  • Kerr, D., Hamilton, P., Cavan, D.A., 2002. Preventing glycaemic excursions in diabetic patients requiring percutaneous endoscopic gastrostomy (PEG) feeding after a stroke. Diabetic Medicine, 19, 1006-1008.
  • Cheyne, E.H., Kerr, D., 2002. Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes/Metabolism Research and Reviews, 18, S43-S48.
  • Richardson, T., Kentish, J., Kerr, D.. Something old, something new… - novel treatments for diabetes in the elderly. CME Geriatric Medicine, 4.
  • Kerr, D.. Food for thought. Diabetes Digest, 1.
  • Kerr, D.. Preventing diabetes – part of the job description or pure empowerment? Diabetes Digest, 4.
  • Kerr, D.. Type 2 or not type 2? Should that be the question? Diabetes and Primary Care, 4.
  • Kerr, D.. Monkey business. Diabetes Digest, 5.
  • Kerr, D.. Exciting times ahead. Diabetes Digest, 6.
  • Everett, J., Kerr, D.. BGAT, BINGO or BASH - what's in a name? Practical Diabetes International, 19.
  • Richardson, T., Kerr, D.. Digital imaging for the follow-up of patients with established diabetic retinopathy. Practical Diabetes International, 19.
  • Kerr, D.. NSF Standards – so good so far. Diabetes Digest, Suppl.
  • Murphy, J., Best, C., Cavan, D.A., Kerr, D.. Nurse/podiatrist-led clinic for patients with non-ulcerated painful neuropathy. Practical Diabetes International, 19.
  • Richardson, T., Kerr, D.. Modern aspects of diabetes monitoring. Postgraduate Doctor Middle East, 25.
  • Kerr, D.. Dreams could be sweeter. Personalising intensive insulin therapy can be achieved by continuous glucose monitoring. Capital Doctor, 14.
  • Kerr, D., Everett, J.. Continuous subcutaneous insulin infusion (CSII), a UK perspective. Infusystems International, 1.
  • Kerr, D., Nicholls, H., Cavan, D.A., 2002. The lost tribes in diabetes. Diabetic Medicine, 19, 703.
  • Kerr, D., 2001. Continuous blood glucose monitoring: Detection and prevention of hypoglycaemia. International Journal of Clinical Practice Supplement.
  • Kerr, D., Cheyne, E.H., Weiss, M., Ryder, J., Cavan, D.A., 2001. Accuracy of MiniMed continuous glucose monitoring system during hypoglycaemia. DIABETOLOGIA, 44, A239.
  • Turner, B., Hejlesen, O.K., Kerr, D., Cavan, D.A., 2001. Impaired absorption and omission of insulin: a novel method of detection using the diabetes advisory system computer model. Diabetes Technology & Therapeutics, 3, 99-109.
  • Khattab, A.D., Ali, I.S., Dils, R., Kerr, D., Jenkinson, D.F., Allen, S., Rana, M.. Nitric oxide synthase and carotid artery plaque morphology. Atherosclerosis Supplements, 2.
  • Khattab, A.D., Ali, I.S., Dils, R., Kerr, D., Jenkinson, D.F., Allen, S.C., Rana, M.. Pro-matrix metalloproteinases (pro-MMP-3) and atherosclerotic carotid artery plaque. Biochemical Society Transactions, 29.
  • Cavan, D.A., Hamilton, P., Everett, J., Kerr, D., 2001. Reducing hospital inpatient length of stay for patients with diabetes. Diabetic Medicine, 18, 162-164.
  • Owen, G., Watson, J.M., McGown, A., Sharma, S., Deary, I.A., Kerr, D., Barrett, G., 2001. Influence of hypoglycaemia, with or without caffeine ingestion, on visual sensation and performance. Clinical Science, 100, 619-626.
  • Turner, B., Jenkins, E.J., Kerr, D., Sherwin, R.S., Cavan, D.A., 2001. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care, 24, 1888-1893.
  • Pratt, E., Miles, P., Kerr, D., 2001. Localized insulin allergy treated with continuous subcutaneous insulin. Diabetic Medicine, 18, 515-516.
  • Kerr, D., 2001. Continuous blood glucose monitoring: detection and prevention of hypoglycaemia. International Journal of Clinical Practice, S123, 43-46.
  • Richardson, T., Kerr, D.. Insulin pump therapy for diabetes – a revival of interest. Modern Diabetes Management, 2.
  • Everett, J., Kerr, D.. Measuring quality of life in diabetes. Journal of Diabetes Nursing, 5.
  • Kerr, D.. National service framework – hope, hype or hell? Diabetes Digest, 1 (Supp).
  • Kerr, D.. National service framework: spare a thought for the troops! Diabetes Digest, 2 (Supp).
  • Kerr, D.. Star qualities or star wars? Diabetes Digest, 2.
  • Sharman, D., Cheyne, E., Cavan, D., Kerr, D., 2000. Safe driving and diabetic complications, myth or reality? DIABETOLOGIA, 43, A235.
  • Cheyne, E., Everett, J., Cavan, D., Kerr, D., 2000. Making sense of type 1 diabetes.: Unrecognised hypoglyceamia during continuous glucose sensing. DIABETOLOGIA, 43, A206.
  • Kerr, D., Cavan, D.A., 2000. Time to pass the monkey (Letter). Hospital Doctor.
  • Watson, J.M., Lunt, M.J., Morris, S., Weiss, M.J., Hussey, D., Kerr, D., 2000. Reversal of caffeine withdrawal by ingestion of a soft beverage. Pharmacol Biochem Behav, 66 (1), 15-18.
  • Kerr, D., 2000. Dull journals. Lancet, 355 (9208).
  • Owen, G., Watson, J., McGown, A., Sharma, S., Deary, I., Kerr, D., Casey, A., Barrett, G., 2000. The effects of hypoglycaemia, with and without caffeine ingestion, on visual sensation and performance. JOURNAL OF PHYSIOLOGY-LONDON, 523, 225P.
  • Begley, J.P., Kerr, D., 2000. Diabetes and lipids - A conundrum [1]. Diabetic Medicine, 17 (8).
  • Watson, J.M., Jenkins, E.J., Hamilton, P., Lunt, M.J., Kerr, D., 2000. Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care, 23, 455-459.
  • Flanagan, D.E.H., Watson, J.M., Everett, J., Cavan, D.A., Kerr, D., 2000. Driving and insulin - consensus, conflict or confusion? Diabetic Medicine, 17, 316-320.
  • Browne, D.L., Avery, L., Turner, B., Kerr, D., Cavan, D.A., 2000. What do patients with diabetes know about their tablets? Diabetic Medicine, 17, 528-531.
  • Watson, J.M., Lunt, M.J., Morris, S., Weiss, M.J., Hussey, D., Kerr, D., 2000. Reversal of caffeine withdrawal by ingestion of a soft beverage. Pharmacology Biochemistry and Behavior, 66, 1518.
  • Ege, B.M., Hejlesen, O.K., Larsen, O.V., Moller, K., Jennings, B., Kerr, D., Cavan, D.A., 2000. Screening for diabetic retinopathy using computer based image analysis and statistical classification. Computer Methods and Programs in Biomedicine, 62, 165-175.
  • Miles, P., Kerr, D.. Very low calorie diets in diabetes. The Bournemouth experience. Journal of Diabetes Nursing, 4.
  • Lunt, M.J., Jenkinson, D.F., Kerr, D., 2000. Transcranial Doppler blood velocity measurement-the effect of changes in velocity profile. Ultrasound in Medicine and Biology, 26, 1145-1151.
  • Everett, J., Kerr, D.. Insulin pumps revisited. Journal of Diabetes Nursing, 4.
  • Sharman, D., Kerr, D.. Practical management of foot ulceration associated with diabetic peripheral neuropathy. The Diabetic Foot, 3.
  • Kerr, D., Richardson, T.. The diabetic foot at the crossroads vanguard or oblivion? The Diabetic Foot, 3.
  • Kerr, D.. And now for something completely different. Diabetes Digest, 1.
  • Lee, B., Cavan, D.A., Kerr, D.. Restructuring, rationing or researching diabetes care. Practical Diabetes International, 17.
  • Begley, J.P., Kerr, D., 2000. Lipids and diabetes – a conundrum? (Letter). Diabetic Medicine, 17, 623-624.
  • Kerr, D., 2000. Dull journals (Letter). The Lancet, 355, 1020.
  • Owen, G., Barrett, G., Watson, J., Kerr, D., 2000. The effects of caffeine ingestion on visual sensation during hypoglycaemia. JOURNAL OF PSYCHOPHYSIOLOGY, 14 (3), 190.
  • Sharman, D., O'Halloran, D., Best, C., Cavan, D., Kerr, D., 1999. Laterality of diabetic foot ulceration fact or fiction? DIABETOLOGIA, 42, A312.
  • Kerr, D., Everett, J., 1999. Role of insulin in the management of diabetes. Prescriber, June 19.
  • Kerr, D., Cavan, D., 1999. The virtual diabetic patient: AIDA on-line. http://www.shodor. Org/aida. Diabetes Metab Res Rev, 15 (3), 226.
  • Kerr, D., Cavan, D., 1999. Clinical trials and new products. Diabetes Metab Res Rev, 15 (3), 228-231.
  • Kerr, D., 1999. Political correctness is behind proposed appraisal system (Letter). British Medical Journal, 318.
  • Khattab, A.D., Ali, I.S., Dils, R., Darke, S.G., Kerr, D., Rana, M.. Serum lipid profile and peripheral arterial disease in diabetic patients. Journal of Endocrinology, 160.
  • Kerr, D., Cavan, D.A., 1999. Treating obese patients with poorly controlled diabetes: confessions of an insulin therapist. Diabetes/Metabolism Research and Reviews, 15, 219-225.
  • Watson, J., Kerr, D., 1999. The best defense against hypoglycemia is to recognize it: is caffeine useful? Diabetes Technology & Therapeutics, 1, 193-200.
  • Ward, A., Kerr, D.. Diabetes, alcohol and hypoglycaemia. Medical Council on Alcoholism, 18.
  • Kerr, D.. Is appraisal the answer to ‘dodgy docs’? Employing Medical and Dental Staff, 15.
  • Watson, J.M., Weiss, M.J., Lunt, M.J., Cavan, D.A., Kerr, D., 1998. Does the brain become tolerant to sustained caffeine use? Implications for treatment hypoglycaemia unawareness. DIABETOLOGIA, 41, A241.
  • Kerr, D., Cavan, D.A., Everett, J., 1998. Diabetes - What's in a name? [1]. Diabetic Medicine, 15 (7), 619.
  • Khattab, A.D., Ali, I.S., Bowley, J., Dils, R., Darke, S.G., Kerr, D., Rana, M., 1998. Protein glycosylation and peripheral vascular disease in diabetic patients. Biochemical Society Transactions, 26, 118.
  • Flanagan, D.E.H., Wood, P., Sherwin, R.S., Debrah, K., Kerr, D., 1998. Gin and tonic and reactive hypoglycemia: what is important–the gin, the tonic, or both? Journal of Clinical Endocrinology & Metabolism, 83, 796-800.
  • Everett, J., Kerr, D.. Nurse-led management of newly diagnosed type-2 diabetes. Journal of Diabetes Nursing, 2.
  • Kerr, D., Cavan, D.A., Jennings, B., Dunnington, C., Gold, D., Crick, M.D., 1998. Beyond retinal screening: digital imaging in the assessment and follow-up of patients with diabetic retinopathy. Diabetic Medicine, 15, 878-882.
  • Everett, J., Kerr, D.. A picture of the impact of newly diagnosed type 2 diabetes. Journal of Diabetes Nursing, 2.
  • Flanagan, D.E.H., Cole, C., Crick, M.D., Kerr, D., 1998. Blurred vision and high blood pressure in a young woman. Postgraduate Medical Journal, 74, 614-615.
  • Everett, J., Kerr, D.. Managing the hypoglycaemic driver. Journal of Diabetes Nursing, 1.
  • Miles, P., Everett, J., Murphy, J., Kerr, D., 1997. Comparison of blood or urine testing by patients with newly diagnosed non-insulin dependent diabetes: patient survey after randomised crossover trial. British Medical Journal, 315, 348-349.
  • Tiarks, C., Fuller, J., Kerr, D., 1997. Loss of diabetic control in an elderly patient. Practitioner, 241 (1577), 431-438.
  • Watson, J., Lunt, M., Murphy, J., Jenkins, E., Kerr, D., 1997. Physiological and psychological effects of acute caffeine withdrawal. DIABETOLOGIA, 40, 1533.
  • Everett, J., Cavan, D., Kerr, D., 1997. Is sweating a useful indicator of nocturnal hypoglycaemia? DIABETOLOGIA, 40, 1291.
  • Jenkins, E., Knott, J., Scott, L., Kerr, D., 1997. Setting diabetes dietary standards - is it worth the effort? DIABETOLOGIA, 40, 1537.
  • Everett, J., Jenkins, E., Miles, P., Cavan, D., Kerr, D., 1997. Long term benefits of immediate, intensive education at diagnosis of NIDDM. DIABETOLOGIA, 40, 41.
  • Ward, A., Kerr, D., 1997. Top 100. Diabetes. General Practitioner, May 23.
  • Thomas, M., Sherwin, R.S., Murphy, J., Kerr, D., 1997. Importance of cerebral blood flow to the recognition of and physiological responses to hypoglycemia. Diabetes, 46, 829-833.
  • Ward, A., Kerr, D.. Treatment options for young adult diabetics. Family Medicine, 1.
  • Flanagan, D., Sherwin, R., Murphy, J., Wood, P., Kerr, D., 1996. Gin and tonic and reactive hypoglycaemia. What is important - gin, tonic or both? DIABETOLOGIA, 39, 826.
  • Frier, B., Deary, I.A., Macdonald, I.A., Kerr, D., Fisher, B.M., 1996. Experimentally induced hypoglycaemia (Letter). The Lancet, 348, 61.
  • Taylor, M., Kerr, D., 1996. Diabetes control and complications: a coming of AGE. The Lancet, 347, 485.
  • Debrah, K., Murphy, J., Kerr, D., Sherwin, R.S., 1996. Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes. The Lancet, 347, 19-24.
  • Kerr, D., 1996. Caffeine and the perception of hypoglycaemia. Biomedicine and Pharmacotherapy, 50 (6-7).
  • Flanagan, D., Kerr, D., 1996. Recurrent hypoglycaemia and long-standing brittle diabetes. Endocrinology and Metabolism Supplement, 3 (1).
  • Flanagan, D.E.H., Creasy, T., Chataway, F., Kerr, D., 1996. Caval umbrella causing obstructive uropathy. Postgraduate Medical Journal, 72, 235-237.
  • Kerr, D.. Non-insulin dependent diabetes - 10 questions answered. Pulse, 12.
  • JENKINS, E., EVERETT, J., MILES, P., KERR, D., 1995. BENEFITS OF NUTRITION FOCUSED CARE FROM DIAGNOSIS OF NIDDM. DIABETES, 44, A236.
  • Debrah, K., Haigh, R., Sherwin, R.S., Murphy, J., Kerr, D., 1995. Effect of acute and chronic caffeine use on the cerebrovascular, cardiovascular and hormonal responses to orthostasis in healthy volunteers. Clinical Science, 89, 475-480.
  • Kerr, D., Haigh, R., 1994. Intensive diabetes treatment: a new deal for old people? Age and Ageing, 23, 89-90.
  • Kerr, D., Sherwin, R.S., Pavalkis, F., Fayad, P.B., Sikorski, L., Rife, F., Tamborlane, W.V., During, M.J., 1993. Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Annals of Internal Medicine, 119, 799-804.
  • Kerr, D., Tamborlane, W.V., Rife, F., Sherwin, R.S., 1993. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin. Journal of Clinical Investigation, 91, 141-147.
  • Kerr, D., Stanley, J.C., Barron, M., Thomas, R., Leatherdale, B.A., Pickard, J.. Symmetry of cerebral blood flow and cognitive responses to hypoglycaemia in humans. Diabetologia, 36.
  • Kerr, D., Diamond, M.P., Tamborlane, W.V., Kerr, S., Sherwin, R.S., 1993. Influence of counterregulatory hormones, independently of hypoglycaemia, on cognitive function, warning symptoms and glucose kinetics. Clinical Science, 85, 197-202.
  • Rennert, N.J., Boulware, S.D., Kerr, D., Caprio, S., Tamborlane, W.V., Sherwin, R.S.. Metabolic effects of rhIGF-1 in normal human subjects. Advances in Experimental Medicine and Biology, 343.
  • Kerr, D., Haigh, R.. Leader: Coffee and diabetes. Practical Diabetes International, 10.
  • Allen, N.H.P., Kerr, D., Smythe, P.J., Martin, N., Osola, K., Thompson, C., 1992. Insulin sensitivity after phototherapy for seasonal affective disorder (Letter). The Lancet, 339.
  • Jones, R.B., Gregory, R., Jones, E.W., Kerr, D., Allison, S.P., McLeod, A., Titterington, D.M., Hedley, A.J.. The quality and relevance of peripheral neuropathy data on a diabetic clinical information system. Diabetic Medicine, 9.
  • Egger, M., Davey Smith, G., Teuscher, A., Kerr, D., Maggs, D., Moriarty, T., Patrick, A.W., Williams, G., 1991. Hypoglycaemia awareness and human insulin (Letter). The Lancet, 338.
  • Kerr, D., Macdonald, I.A., Tattersall, R.B.. Patients with type-1 diabetes adapt acutely to sustained mild hypoglycaemia. Diabetic Medicine, 8.
  • Kerr, D., Reza, M., Smith, N., Leatherdale, B.A.. Importance of insulin in subjective, cognitive, and hormonal responses to hypoglycemia in patients with IDDM. Diabetes, 40.
  • Tattersall, R.B., Gregory, R., Selby, C., Kerr, D., Heller, S.R., 1990. Course of brittle diabetes: 12 year follow up. British Medical Journal, 302.
  • Kerr, D., Macdonald, I.A., Heller, S.R., Tattersall, R.B.. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with Type 1 (insulin-dependent) diabetes. Diabetologia, 33.
  • Kerr, D., Macdonald, I.A., Heller, S.R., Tattersall, R.B.. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects. British Journal of Clinical Pharmacology, 29.
  • Kerr, D., Skinner, D.W., Hosking, D.J., Bradley, P.J., Salama, F.D.. Maintenance of serum calcium after total thyroparathyroidectomy. European Journal of Surgical Oncology, 16.
  • Stone, M.D., Hawthorne, M.B., Kerr, D., Webster, G., Hosking, D.J.. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate. Journal of Bone and Mineral Research, 5.
  • Kerr, D., Macdonald, I.A., Hillier, J., Tattersall, R.B., 1989. Adrenaline response to hypoglycaemia and insulin species (Letter). The Lancet, 333.
  • Kerr, D., Macdonald, I.A., Tattersall, R.B.. Influence of duration of hypoglycemia on the hormonal counterregulatory response in normal subjects. Journal of Clinical Endocrinology and Metabolism, 68.
  • Kerr, D., Macdonald, I.A., Tattersall, R.B.. Adaptation to mild hypoglycaemia in normal subjects despite sustained increases in counter-regulatory hormones. Diabetologia, 32.
  • Kerr, D., Kerr, S.. Diabetic camps for children - effects on control and hypoglycaemia. Practical Diabetes International, 5.
  • Hosking, D.J., Kerr, D.. Mechanisms of parathyroid hormone resistance in pseudohypoparathyroidism. Clinical Science, 74.
  • Kerr, D., Everett, J., 1988. Changing from porcine to human insulin. Drugs, 47, 286-296.
  • Kerr, D., Hosking, D.J.. Pseudohypoparathyroidism: clinical Expression of PTH resistance. QJM, 65.
  • Kerr, D., Hooper, W.L., Jones, D.M.. A rare case of meningitis due to Neisseria meningitidis group 29E. Journal of Infection, 13.
  • Kerr, D.. Cuba Libre (Letter). British Medical Journal, 293.

Chapters

  • Nolan, J.J., Danne, T., Diamant, M., Hood, G., Kautzky-Willer, A., Kerr, D., Mitrakou, A., Nilsson, P.A., Pacini, G., 2010. Clinical science and care incorporating the development of a European Platform for Clinical Research in Diabetes (EPCRD). Roadmap for diabetes research in Europe. DIAMAP, 73-114.
  • Kerr, D.. Counterregulatory deficiences in diabetes. In: Frier, B.M., Fisher, M., eds. Hypoglycaemia in clinical disease. Chichester: Wiley.
  • Richardson, T., Kerr, D.. Moderators and management of hypoglycaemia. In: Frier, B.M., Fisher, M., eds. Hypoglycaemia in clinical disease. Chichester: Wiley.
  • Cheyne, E.H., Kerr, D.. Future prospects in insulin therapy. In: Barnett, A.H., eds. Insulin made easy. London: Medical Education Partnership.
  • Kerr, D.. Counterregulatory deficiences in diabetes. In: Frier, B.M., Fisher, B.M., eds. Hypoglycaemia in clinical diabetes. Chichester: J Wiley.
  • Kerr, D.. Diabetic ketoacidosis and surgery and diabetes. In: Dunnill, R., Colvin, P., eds. Clinical and resuscitative data : a compendium of acute medical data. Oxford: Blackwell Science.
  • Kerr, D.. Drugs and alcohol. In: Frier, B.M., Fisher, M., eds. Hypoglycaemia and diabetes : clinical and physiological aspects. London: Edward Arnold.
  • Kerr, D., Tattersall, R.B.. Diabetes and old age. In: Alberti, K.G.M.M., Krall, L.P., eds. The Diabetes Annual. Amsterdam: Elsevier.

Conferences

  • Gribble, L., Gouni, R., Eriksson, M., Boyle, J., Kerr, D., Coppini, D., 2010. A double-blind randomised study comparing the effects of pregabalin, duloxetine and amitryptiline on aspects of neuropathic pain, mood and sleep in diabetic subjects with painful neuropathy. DIABETOLOGIA, 53, S16-S17.
  • Rana, O., Zouwail, S., Coppini, D.V., Senior, R., Begley, J., Kerr, D., Byrne, C.D., Greaves, K., 2009. The Effect of Insulin-induced Hypoglycaemia an Myocardial Blood Flow in Patients With Type 1 Diabetes Mellitus. CIRCULATION, 120 (18), S368.
  • Purandare, L., Hickish, T., Astras, G., Penfold, S., Thomas, F., Kerr, D., 2009. Impaired glucose tolerance in non-diabetic women during adjuvant chemotherapy for breast cancer. EJC SUPPLEMENTS, 7 (2), 309.
  • Eriksson, M.E.V., Gouni, R., Gribble, L.C., Coppini, D.D., Kerr, D., Boyle, J., 2008. Investigation of the impact of painful diabetic peripheral neuropathy on sleep quality and sleep architecture in type 1 and 2 diabetic patients using polysomnography. DIABETOLOGIA, 51, S507.
  • Gribble, L., Korimbocus, A., Middleton, B., Gouni, R., Kerr, D., Coppini, D.V., Boyle, J., 2008. Sleep in painful diabetic peripheral neuropathy: Subjective measures and actigraphy analysis. SLEEP, 31, A299.
  • Boyle, J., Mills, S.L., Gouni, R., Coppini, D.V., Kerr, D., Eriksson, M.E., 2008. Painful diabetic peripheral neuropathy: Assessment of quality of sleep and sleep continuity. SLEEP, 31, A299.
  • Eriksson, M.E., Gribble, L.C., Gouni, R., Kerr, D., Coppini, D.V., Boyle, J., 2008. Impact of painful diabetic peripheral neuropathy on sleep architecture using polysomnography. SLEEP, 31, A299.
  • Hart, T., Kerr, D., Begley, J., 2007. Influence of lifestyle change on Glucagon-Like Peptide-1 in new onset type 2 diabetes. Pilot study. DIABETOLOGIA, 50, S339.
  • Newman, S., Hurel, S., Cooke, D., Steed, L., Ahlquist, J., Weaver, J., Kerr, D., Barnard, M., Casbard, A., Meredith, S., Nunn, A., 2007. RCT of continuous glucose monitoring devices on HbA1C -: The MITRE study. DIABETOLOGIA, 50, S115-S116.
  • Cooke, D., Steed, L., Hurel, S.J., Nunn, A., Ahlquist, J., Weaver, J., Kerr, D., Barnard, M., Newman, S., 2007. Use and acceptability of two minimally invasive continuous blood glucose monitors. DIABETOLOGIA, 50, S418-S419.
  • Bolinder, J., Deiss, D., Riveline, J., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., Phillip, M., 2005. Guardian® RT Continuous Glucose Monitoring System with real time glucose values and alarms functions:: a new tool for improving glucose control in patients with type 1 diabetes mellitus? DIABETOLOGIA, 48, A49.
  • Fegan, G., Hamliton, P., Kerr, D., 2004. A prospective study to assess the clinical application of glucose monitoring in hospitalised patients with Type 2 diabetes. DIABETOLOGIA, 47, A320.
  • Hoogma, R.P.L., Hammond, P.J., Gomis, R., Kerr, D., Bruttomesso, D., Bouter, P., Wiefels, K.J., de la Calle, H., Schweitzer, D.H., Pfohl, M., Torlone, E., Krinelke, L.G., 2004. Comparison of continuous subcutaneous insulin infusion (CSII) vs. multiple daily insulin injections (MDI) in regard to metabolic control. Results of the 5-Nations trial. DIABETOLOGIA, 47, A32-A33.
  • Bolli, G.B., Capani, F., Kerr, D., Thomas, R., Torlone, E., Selam, J.L., Sola-Gazagnes, A., Vitacolonna, E., 2004. Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: a randomized, open, parallel study. DIABETOLOGIA, 47, A301.
  • James, J., Thomas, P., Kerr, D., 2004. Longitudinal results from CHOPPS (Christchurch Obesity Prevention Project in Schools). INTERNATIONAL JOURNAL OF OBESITY, 28, S33.
  • James, J., Thomas, P., Cavan, D.A., Kerr, D., 2004. Longitudinal Results from CHOPPS (Christchurch Obesity Prevention Project in Schools). In: 40th Annual Meeting of the European Association for the Study of Diabetes 05/09/2004 Munich, Germany.
  • James, J., Thomas, P., Cavan, D.A., Kerr, D.. Longitudinal Results from CHOPPS (Christchurch Obesity Prevention Project in Schools). In: 13th European Congress on Obesity 26/05/2004 Prague, Czech Republic.
  • Everett, J.D., Jenkins, E., Kerr, D., Cavan, D.A., 2003. Using computer modelling to enhance structured education for people with Type 1 diabetes. DIABETOLOGIA, 46, A88.
  • James, J., Thomas, P., Cavan, D.A., Kerr, D., 2003. CHOPPS: The Christchurch Obesity Prevention Programme in Schools. In: IDF-Paris 2003: 18th International Diabetes Federation Congress 24/08/2003 Paris, France.
  • James, J., Thomas, P., Kerr, D.. Apples, not Pears. In: Diabetes UK Meeting 19/03/2003 Glasgow, Scotland.
  • Cheyne, E.H., Weiss, M.J., Lunt, M.J., Thomas, P., Cavan, D.A., Kerr, D.. Influence of Combination of Mild Hypoglycemia and Modest Alcohol Ingestion on Cognitive Performance in Type 1 Diabetes. In: American Diabetes Association Conference 2001.
  • Trowbridge, S., Kerr, D., Cavan, D.A., Weiss, M.J., Thomas, P.. Hitting the target through patient empowerment. Randomised control trial of self monitoring and self adjustment of antihypertensive therapy in type 2 diabetes. In: American Diabetes Association Conference 2001.

Reports

The data on this page was last updated at 05:00 on February 18, 2026.